Drug profile · INN
desoxycorticosterone pivalate
PERCORTEN
desoxycorticosterone pivalate (PERCORTEN) is a mineralocorticoid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — desoxycorticosterone pivalate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
desoxycorticosterone pivalate (PERCORTEN) is a mineralocorticoid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Mineralocorticoid receptor agonist
Primary target: Mineralocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is desoxycorticosterone pivalate?
desoxycorticosterone pivalate (PERCORTEN) is a mineralocorticoid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for desoxycorticosterone pivalate?
PERCORTEN is a marketed brand name for desoxycorticosterone pivalate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of desoxycorticosterone pivalate?
desoxycorticosterone pivalate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.